EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Hand-dominant joint involvement pattern associates with favourable, and polyarthritis with unfavourable, treatment response to both csDMARDs and bDMARDs in early rheumatoid arthritis: a combined analysis of NORD-STAR and BeSt trials

Yasuo Nagafuchi, Tjardo D Maarseveen, Kristina Lend, Anna Rudin, Bjorn Gudbjornsson, Dan Nordström, Espen A Haavardsholm, Gerdur Gröndal, Jon Lampa, Kim Hørslev Petersen, Marte Schrumpf Heiberg, Merete Lund Hetland und 9 weitere

Annals of the Rheumatic Diseases · 2026-07 · 85 (7) · 1218-1228

DOI: 10.1016/j.ard.2026.02.005 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Annals of the Rheumatic Diseases, 2026-07. Verfasst von Yasuo Nagafuchi und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: y.nagafuchi@lumc.nl. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Antirheumatic Agents, Hand Joints, Biological Products. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw, Horizon Europe.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To investigate the association between joint involvement pattern (JIP) subgroups and treatment responses to conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) and biological disease-modifying antirheumatic drugs (bDMARDs), and to compare the impact of JIP subgroups with other clinical parameters in treatment-naïve patients with early rheumatoid arthritis (RA). METHODS: An individual patient data meta-analysis was conducted using 2 randomised controlled trials, NOrdic Rheumatic Diseases Strategy Trials And Registries (NORD-STAR) and Behandel-Strategieën (BeSt), including 1250 treatment-naïve patients with early RA. JIP subgroup assignment was based on 4 previously identified subgroups defined by baseline clinical characteristics, primarily joint involvement in the 66/68 joint scheme. Treatment outcomes were measured using the longitudinal Clinical Disease Activity Index (CDAI) and other disease activity indices through week 48. Associations of the JIP subgroups and other clinical predictors were evaluated using a mixed-model analysis. RESULTS: Patients with a hand-dominant JIP (JIP-Hand) showed significantly better CDAI scores after treatment (Beta for CDAI = -1.4 [95% CI, -2.3 to -0.55]; p = .0016), whereas those with a polyarthritis pattern (JIP-Poly) exhibited worse outcomes (Beta = 0.95 [95% CI, 0.064-1.8]; p = .035). Female sex was also associated with worse CDAI scores (Beta = 1.2 [95% CI, 0.40-2.0]; p = .0031), whereas anticitrullinated protein antibodies did not show a significant association (Beta = 0.19 [95% CI, -0.69 to 1.1]; p = .67). When compared across groups, csDMARDs and combined bDMARDs were similarly effective in the respective JIP subgroups (interaction p > .10). CONCLUSIONS: In early RA, csDMARD and bDMARD treatments resulted in the greatest improvement in disease activity in JIP-Hand and the least improvement in JIP-Poly.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidAntirheumatic AgentsHand JointsBiological ProductsArthritisHumansFemaleTreatment OutcomeMaleMiddle AgedSeverity of Illness IndexRandomized Controlled Trials as TopicTreatment Effect Heterogeneity

Substanzen

Antirheumatic AgentsBiological Products

Autor:innen und Institutionen

  • Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: y.nagafuchi@lumc.nl.
  • Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, Amsterdam, The Netherlands; Division of Rheumatology, Department of Medicine, Center for Molecular Medicine (CMM), Karolinska Inst…
  • Rheumatology, Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, Gothenburg, Sweden.
  • Centre for Rheumatology Research, Landspitali University Hospital, Reykjavik, Iceland; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Departments of Medicine and Rheumatology, Helsinki University Hospital, Helsinki, Finland; University of Helsinki, Helsinki, Finland.

Förderung

  • ZonMw
  • Horizon Europe

Zitieren

APA

Nagafuchi, Y., Maarseveen, T. D., Lend, K., Rudin, A., Gudbjornsson, B., Nordström, D., Haavardsholm, E. A., Gröndal, G., Lampa, J., Petersen, K. H., Heiberg, M. S., Hetland, M. L., Nurmohamed, M., Østergaard, M., van Vollenhoven, R., Uhlig, T., Sokka-Isler, T., van den Akker, E. B., Huizinga, T. W. J., …, & Knevel, R. (2026). Hand-dominant joint involvement pattern associates with favourable, and polyarthritis with unfavourable, treatment response to both csDMARDs and bDMARDs in early rheumatoid arthritis: a combined analysis of NORD-STAR and BeSt trials. Annals of the Rheumatic Diseases, 85(7), 1218-1228. https://doi.org/10.1016/j.ard.2026.02.005

Vancouver

Nagafuchi Y, Maarseveen TD, Lend K, Rudin A, Gudbjornsson B, Nordström D, et al. Hand-dominant joint involvement pattern associates with favourable, and polyarthritis with unfavourable, treatment response to both csDMARDs and bDMARDs in early rheumatoid arthritis: a combined analysis of NORD-STAR and BeSt trials. Annals of the Rheumatic Diseases. 2026;85(7):1218-1228. doi:10.1016/j.ard.2026.02.005

BibTeX
@article{Nagafuchi2026,
  author = {Nagafuchi, Yasuo and Maarseveen, Tjardo D and Lend, Kristina and Rudin, Anna and Gudbjornsson, Bjorn and Nordström, Dan and Haavardsholm, Espen A and Gröndal, Gerdur and Lampa, Jon and Petersen, Kim Hørslev and Heiberg, Marte Schrumpf and Hetland, Merete Lund and Nurmohamed, Mike and Østergaard, Mikkel and van Vollenhoven, Ronald and Uhlig, Till and Sokka-Isler, Tuulikki and van den Akker, Erik B and Huizinga, Tom W J and Bergstra, Sytske Anne and Knevel, Rachel},
  title = {Hand-dominant joint involvement pattern associates with favourable, and polyarthritis with unfavourable, treatment response to both csDMARDs and bDMARDs in early rheumatoid arthritis: a combined analysis of NORD-STAR and BeSt trials},
  journal = {Annals of the Rheumatic Diseases},
  year = {2026},
  volume = {85},
  number = {7},
  pages = {1218--1228},
  doi = {10.1016/j.ard.2026.02.005}
}
Kostenlos starten →